1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.
  2. Dear Guest, we realise advertising is annoying, it is however necessary to help us be a sustainable resource for all, if you want to go advert free then please use the following link to subscribe for £5 a month: Click here
    Dismiss Notice

(IOF) Iofina Share Chat

Discussion in 'General Share Chat (IOF)' started by Squire007, Mar 17, 2016.

Tags:
  1. Groucho

    Groucho Member

    Messages:
    9,136
    Reputation:
    374
  2. Groucho

    Groucho Member

    Messages:
    9,136
    Reputation:
    374
    9 May 2022


    Iofina plc

    ("Iofina", the "Company" or the "Group")

    (LSE AIM: IOF)


    2021 FULL YEAR RESULTS

    FOURTH SUCCESSIVE YEAR OF RECORD REVENUE AND EBITDA

    Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, announces its audited full year results for the 12 months to 31 December 2021 (the "Period").

    Bounce back in demand boosted sales and profits in 2021:

    · Revenue increased by 31% to $39.0m to (2020: $29.7m)

    · Gross profit increased by 28% to $10.7m (2020: $8.4m)

    · EBITDA improved by 47% to $6.9m (2020: $4.7m)

    · Operating profit increased by 78% to $5.2m (2020: $2.9m)

    · Profit before tax increased by 301% to $5.1m (2020: $1.3m)


    Strong balance sheet and further reduction in net debt:

    · Cash flow generation of $5.9m reduced net debt from $8.9m to $3.0m

    · Finance expense decreased by 83% to $0.3m (2020: $1.7m)


    Investing for growth:

    · Commenced site negotiation process for IO#9 construction in the Period.

    · Capital investment into projects and equipment was $1.5m (2020: $2.4m) including process improvements and replacements at the Iofina Chemical plant


    2022 so far:

    · Current global iodine spot prices have reached $60/kg and above, up 20% since the beginning of 2022

    · Production of 103.8 MT of crystalline iodine in Q1 from Iofina's five IOsorb® plants

    · Finalising terms with new brine supply partner for IO#9 plant



    Commenting, President and CEO Dr. Tom Becker, stated:

    "Today we are proud to announce that 2021 was our fourth consecutive year of record revenues and EBITDA. By executing our fundamental business plans coupled with a strong bounce back in demand for iodine and its end-use products in the wake of the COVID-19 pandemic, we were able to deliver enhanced revenues and profits and significantly reduce our debt through strong cash generation. Our margins have been bolstered by a strong iodine price particularly over the last 6 months, and we expect these high prices to continue during 2022.

    "Whilst lower brine supply from our oil and gas partners impacted iodine production in the Period, we are hopeful supply will improve this year with oil and gas companies now reinvesting in their assets to boost production. The delay to the construction of our IO#9 plant has been frustrating, but we are now finalising an agreement with a new brine supply partner and expect to have a further update on this shortly.

    "Iofina Chemical continued to perform well and was integral to the Group's sales and earnings. We have been working on enhancements to improve efficiencies and capacity for certain iodine and non-iodine products, and we expect a laboratory upgrade in Q2 2022 to improve the Company's R&D capabilities.

    "With market fundamentals remaining favourable, a much-improved balance sheet, and continued strategic investment in our growth, the Board remains confident in the future success of the business and looks forward to keeping shareholders updated on progress."

    Investor Presentation

    The Company plans to provide a presentation relating to the Company's outlook and these 2021 results. Details will be provided soon via a RNS Reach announcement.
     
  3. Groucho

    Groucho Member

    Messages:
    9,136
    Reputation:
    374
    Iofina PLC on the company's record 2021 performance

    Tom Becker, chief executive of Iofina PLC (AIM:IOF, OTC:IOFNF), spoke to Proactive London about the company's full-year results.

    The company announced its fourth consecutive year of record revenues and underlying earnings, with pre-tax profits quadrupling.

    Becker added that the company is actively seeking further growth and expansion opportunities.


     
  4. Groucho

    Groucho Member

    Messages:
    9,136
    Reputation:
    374
  5. Groucho

    Groucho Member

    Messages:
    9,136
    Reputation:
    374
    20 May 2022

    RNS REACH

    Iofina plc

    ("Iofina", the "Company" or the "Group")

    (LSE AIM: IOF)



    Investor Presentation

    Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to announce that Tom Becker, CEO and Malcolm Lewin, CFO will provide a live presentation relating to 2021 Results & Company Update via the Investor Meet Company platform on 27th May 2022 at 2:00pm BST.

    The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

    Investors can sign up to Investor Meet Company for free and add to meet Iofina plc via: https://www.investormeetcompany.com/iofina-plc/register-investor

    Investors who already follow Iofina plc on the Investor Meet Company platform will automatically be invited.
     
  6. Groucho

    Groucho Member

    Messages:
    9,136
    Reputation:
    374
    20 June 2022

    Iofina plc

    ("Iofina", the "Company" or the "Group")

    (LSE AIM: IOF)


    Appointment of Chrystal Capital Partners LLP as Strategic Financial Advisor


    Iofina plc, manufacturers of specialty chemical products and specialists in the exploration and production of iodine, today announces the appointment of Chrystal Capital Partners LLP ("Chrystal Capital") as a financial advisory partner. Chrystal Capital will be providing strategic advice on the Company's approach to the equity markets and business growth, including helping to engage with new investment funds, Single Family Offices (SFOs), and Ultra High Net Worth Individuals (UHNWIs).

    Iofina is one of the lowest cost raw iodine and iodine derivative companies in the world. With spot iodine prices recently reaching $70/kg and demand high for iodine derivatives, market conditions are in Iofina's favour. Debt has been significantly reduced, and with five iodine productions plants in operation and vertical integration into iodine derivatives through Iofina Chemical, along with plans for additional iodine plants, the Company is in its strongest ever position.

    Against this backdrop, in addition to organic growth within our core businesses, the Company will further explore business partnerships and combinations in the market and explore wider opportunities to drive shareholder value with the support of Chrystal Capital.

    Commenting, President and CEO Dr. Tom Becker, stated: "Over the past few years we have worked hard to position Iofina as one of the lowest cost iodine producers in the world in a market that continues to show solid growth. The appointment of Chrystal Capital Partners solidifies our intent to consider and evaluate opportunities to grow the business beyond our organic growth plans. We look forward to working closely with Chrystal Capital to assess how we can further unlock and drive shareholder value going forward".

    Kingsley Wilson, Partner at Chrystal Capital Partners, stated: "Having been involved with Iofina as a private company, and subsequently bringing it to the London market in 2008, I'm personally delighted to be working with the Iofina management team again to assist in the next stage of growth to build value. The iodine and iodine derivatives market globally is in robust health and there are multiple opportunities for Iofina, with a strong market reputation and solid financial strength, to take advantage of to scale the existing business. We look forward to working with the Company to assess and execute its strategic plan".
     

Share This Page